21-OHD

Clinical trials for 21-OHD explained in plain language.

Never miss a new study

Get alerted when new 21-OHD trials appear

Sign up with your email to follow new studies for 21-OHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Trial tests new drug to help kids with rare hormone disorder

Disease control Terminated

This study tested a drug called tildacerfont in children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a rare genetic hormone disorder. The main goal was to see if the drug was safe and if it could help control the disease, potentially allowing for a reduction in the st…

Matched conditions: 21-OHD

Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control

Last updated Apr 02, 2026 07:12 UTC

21-OHD

Get alerted when new 21-OHD trials appear

Trial tests new drug to help kids with rare hormone disorder